Identifies cancer-associated fibroblast roles in immune modulation in pseudomyxoma peritonei, suggesting new therapeutic targets.
Pseudomyxoma peritonei (PMP) is an ultra-rare mucinous neoplasm with extensive stromal remodeling, yet the role of cancer-associated fibroblasts (CAFs) remains poorly defined. A PMP-derived CAF culture was established and characterized through multiple omics and phenotypic assays. Single-cell transcriptomic profiling revealed two distinct CAF populations: fibroblast-derived CAFs enriched for characteristic CAF functionalities and mesothelial-derived CAFs expressing mesothelial markers and pathways linked to metabolism and motility, consistent with mesothelial-to-mesenchymal transition. PMP CAFs exhibit baseline invasive and contractile properties and acquire an inflammatory CAF-like phenotype upon TNF-α/IL-1β stimulation, accompanied by altered proteomic and secretome profiles. Conditioned media from PMP CAFs further promoted macrophage polarization, highlighting their role in shaping the immune microenvironment. In conclusion, our findings reveal a previously uncharacterized role for CAF in PMP, highlighting their contribution to immune modulation in this extremely scarce peritoneal malignancy.
No takes yet. Share an insight, caveat, or question.
Vuyst et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: